pages_aktie_[isin]__11
pages_aktie_[isin]__12
components_charts_QuoteChart_19 | Paradigm Biopharmaceuticals components_charts_QuoteChart_3 |
---|---|
01.07.2025 | 0,38 undefined |
30.06.2025 | 0,31 undefined |
27.06.2025 | 0,32 undefined |
26.06.2025 | 0,34 undefined |
25.06.2025 | 0,32 undefined |
24.06.2025 | 0,33 undefined |
23.06.2025 | 0,29 undefined |
20.06.2025 | 0,30 undefined |
19.06.2025 | 0,30 undefined |
18.06.2025 | 0,31 undefined |
17.06.2025 | 0,31 undefined |
16.06.2025 | 0,29 undefined |
13.06.2025 | 0,29 undefined |
12.06.2025 | 0,30 undefined |
11.06.2025 | 0,30 undefined |
10.06.2025 | 0,29 undefined |
06.06.2025 | 0,29 undefined |
05.06.2025 | 0,30 undefined |
04.06.2025 | 0,31 undefined |
03.06.2025 | 0,31 undefined |
chart_toolbar_3y
chart_toolbar_5y
chart_toolbar_10y
components_charts_BaseChart_0
chart_toolbar_max
components_charts_RevenueChart_14 | Paradigm Biopharmaceuticals components_charts_RevenueChart_8 | Paradigm Biopharmaceuticals components_charts_RevenueChart_10 | Paradigm Biopharmaceuticals components_charts_RevenueChart_9 |
---|---|---|---|
2027e | 0 undefined | -86,86 number_format_mio undefined | -36,45 number_format_mio undefined |
2026e | 0 undefined | -66,66 number_format_mio undefined | -34,33 number_format_mio undefined |
2025e | 3,03 number_format_mio undefined | -48,99 number_format_mio undefined | -25,12 number_format_mio undefined |
2024 | 6,52 number_format_mio undefined | -58,59 number_format_mio undefined | -58,65 number_format_mio undefined |
2023 | 8,49 number_format_mio undefined | -51,59 number_format_mio undefined | -51,91 number_format_mio undefined |
2022 | 7,89 number_format_mio undefined | -40,12 number_format_mio undefined | -39,25 number_format_mio undefined |
2021 | 8,58 number_format_mio undefined | -34,62 number_format_mio undefined | -34,30 number_format_mio undefined |
2020 | 4,65 number_format_mio undefined | -12,31 number_format_mio undefined | -12,30 number_format_mio undefined |
2019 | 3,25 number_format_mio undefined | -8,70 number_format_mio undefined | -15,63 number_format_mio undefined |
2018 | 2,74 number_format_mio undefined | -6,19 number_format_mio undefined | -6,19 number_format_mio undefined |
2017 | 1,85 number_format_mio undefined | -4,28 number_format_mio undefined | -4,28 number_format_mio undefined |
2016 | 1,39 number_format_mio undefined | -2,92 number_format_mio undefined | -2,92 number_format_mio undefined |
2015 | 7 300,00 undefined | -1,57 number_format_mio undefined | -1,57 number_format_mio undefined |
2014 | 0 undefined | -40 000,00 undefined | -40 000,00 undefined |
components_charts_RevenueChart_8 | components_charts_RevenueChart_10 | components_charts_RevenueChart_9 | |
---|---|---|---|
2014 | 0 AUD | -40 000,00 AUD | -40 000,00 AUD |
2015 | 7 300,00 AUD | -1,57 number_format_mio AUD | -1,57 number_format_mio AUD |
2016 | 1,39 number_format_mio AUD | -2,92 number_format_mio AUD | -2,92 number_format_mio AUD |
2017 | 1,85 number_format_mio AUD | -4,28 number_format_mio AUD | -4,28 number_format_mio AUD |
2018 | 2,74 number_format_mio AUD | -6,19 number_format_mio AUD | -6,19 number_format_mio AUD |
2019 | 3,25 number_format_mio AUD | -8,70 number_format_mio AUD | -15,63 number_format_mio AUD |
2020 | 4,65 number_format_mio AUD | -12,31 number_format_mio AUD | -12,30 number_format_mio AUD |
2021 | 8,58 number_format_mio AUD | -34,62 number_format_mio AUD | -34,30 number_format_mio AUD |
2022 | 7,89 number_format_mio AUD | -40,12 number_format_mio AUD | -39,25 number_format_mio AUD |
2023 | 8,49 number_format_mio AUD | -51,59 number_format_mio AUD | -51,91 number_format_mio AUD |
2024 | 6,52 number_format_mio AUD | -58,59 number_format_mio AUD | -58,65 number_format_mio AUD |
2025e | 3,03 number_format_mio AUD | -48,99 number_format_mio AUD | -25,12 number_format_mio AUD |
2026e | 0 AUD | -66,66 number_format_mio AUD | -34,33 number_format_mio AUD |
2027e | 0 AUD | -86,86 number_format_mio AUD | -36,45 number_format_mio AUD |
components_StockTable_20
components_StockTable_21
components_StockTable_17
components_StockTable_18
components_StockTable_19
components_StockDataTable_IncomeStatement_0 |
---|
components_StockTable__1 |
components_StockTable__2 |
components_StockDataTable_IncomeStatement_3 |
components_StockDataTable_IncomeStatement_17 |
components_StockTable__6 |
components_StockTable__11 |
components_StockTable__12 |
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 0 | 1,00 | 1,00 | 2,00 | 3,00 | 4,00 | 8,00 | 7,00 | 8,00 | 6,00 | 3,00 | 0 | 0 |
- | - | - | - | 100,00 | 50,00 | 33,33 | 100,00 | -12,50 | 14,29 | -25,00 | -50,00 | - | - |
- | - | 600,00 | 600,00 | 300,00 | 200,00 | 150,00 | 100,00 | 100,00 | 100,00 | 100,00 | 200,00 | - | - |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 8,00 | 7,00 | 8,00 | 6,00 | 0 | 0 | 0 |
0 | -1,00 | -2,00 | -4,00 | -6,00 | -15,00 | -12,00 | -34,00 | -39,00 | -51,00 | -58,00 | -25,00 | -34,00 | -36,00 |
- | - | 100,00 | 100,00 | 50,00 | 150,00 | -20,00 | 183,33 | 14,71 | 30,77 | 13,73 | -56,90 | 36,00 | 5,88 |
47,69 | 47,69 | 83,18 | 98,58 | 117,01 | 144,08 | 202,56 | 212,18 | 240,95 | 289,67 | 350,36 | 0 | 0 | 0 |
- | - | - | - | - | - | - | - | - | - | - | - | - | - |
chart_toolbar_3y
chart_toolbar_5y
chart_toolbar_10y
components_charts_BaseChart_0
chart_toolbar_max
Paradigm Biopharmaceuticals components_charts_MarginsChart_15 | Paradigm Biopharmaceuticals components_charts_MarginsChart_16 | Paradigm Biopharmaceuticals components_charts_MarginsChart_17 | Paradigm Biopharmaceuticals components_charts_MarginsChart_16 |
---|---|---|---|
2027e | 99,86 % | 0 % | 0 % |
2026e | 99,86 % | 0 % | 0 % |
2025e | 99,86 % | -1 616,67 % | -829,20 % |
2024 | 99,86 % | -898,67 % | -899,60 % |
2023 | 99,78 % | -607,59 % | -611,32 % |
2022 | 98,18 % | -508,20 % | -497,23 % |
2021 | 98,84 % | -403,60 % | -399,81 % |
2020 | 99,86 % | -265,09 % | -264,75 % |
2019 | 99,86 % | -268,01 % | -481,50 % |
2018 | 99,86 % | -226,22 % | -226,22 % |
2017 | 99,86 % | -231,25 % | -231,25 % |
2016 | 99,86 % | -209,75 % | -209,75 % |
2015 | 99,86 % | -21 442,47 % | -21 442,47 % |
2014 | 99,86 % | 0 % | 0 % |
components_charts_MarginsChart_15 | components_charts_MarginsChart_17 | components_charts_MarginsChart_16 | |
---|---|---|---|
2014 | 99,86 % | 0 % | 0 % |
2015 | 99,86 % | -21 442,47 % | -21 442,47 % |
2016 | 99,86 % | -209,75 % | -209,75 % |
2017 | 99,86 % | -231,25 % | -231,25 % |
2018 | 99,86 % | -226,22 % | -226,22 % |
2019 | 99,86 % | -268,01 % | -481,50 % |
2020 | 99,86 % | -265,09 % | -264,75 % |
2021 | 98,84 % | -403,60 % | -399,81 % |
2022 | 98,18 % | -508,20 % | -497,23 % |
2023 | 99,78 % | -607,59 % | -611,32 % |
2024 | 99,86 % | -898,67 % | -899,60 % |
2025e | 99,86 % | -1 616,67 % | -829,20 % |
2026e | 99,86 % | 0 % | 0 % |
2027e | 99,86 % | 0 % | 0 % |
chart_toolbar_3y
chart_toolbar_5y
chart_toolbar_10y
components_charts_BaseChart_0
chart_toolbar_max
components_charts_RevenuePerShareChart_17 | Paradigm Biopharmaceuticals components_charts_RevenuePerShareChart_10 | Paradigm Biopharmaceuticals components_charts_RevenuePerShareChart_12 | Paradigm Biopharmaceuticals components_charts_RevenuePerShareChart_11 |
---|---|---|---|
2027e | 0 undefined | 0 undefined | -0,10 undefined |
2026e | 0 undefined | 0 undefined | -0,10 undefined |
2025e | 0,01 undefined | 0 undefined | -0,07 undefined |
2024 | 0,02 undefined | -0,17 undefined | -0,17 undefined |
2023 | 0,03 undefined | -0,18 undefined | -0,18 undefined |
2022 | 0,03 undefined | -0,17 undefined | -0,16 undefined |
2021 | 0,04 undefined | -0,16 undefined | -0,16 undefined |
2020 | 0,02 undefined | -0,06 undefined | -0,06 undefined |
2019 | 0,02 undefined | -0,06 undefined | -0,11 undefined |
2018 | 0,02 undefined | -0,05 undefined | -0,05 undefined |
2017 | 0,02 undefined | -0,04 undefined | -0,04 undefined |
2016 | 0,02 undefined | -0,04 undefined | -0,04 undefined |
2015 | 0,00 undefined | -0,03 undefined | -0,03 undefined |
2014 | 0 undefined | -0,00 undefined | -0,00 undefined |
components_charts_RevenuePerShareChart_10 | components_charts_RevenuePerShareChart_12 | components_charts_RevenuePerShareChart_11 | |
---|---|---|---|
2014 | 0 AUD | -0,00 AUD | -0,00 AUD |
2015 | 0,00 AUD | -0,03 AUD | -0,03 AUD |
2016 | 0,02 AUD | -0,04 AUD | -0,04 AUD |
2017 | 0,02 AUD | -0,04 AUD | -0,04 AUD |
2018 | 0,02 AUD | -0,05 AUD | -0,05 AUD |
2019 | 0,02 AUD | -0,06 AUD | -0,11 AUD |
2020 | 0,02 AUD | -0,06 AUD | -0,06 AUD |
2021 | 0,04 AUD | -0,16 AUD | -0,16 AUD |
2022 | 0,03 AUD | -0,17 AUD | -0,16 AUD |
2023 | 0,03 AUD | -0,18 AUD | -0,18 AUD |
2024 | 0,02 AUD | -0,17 AUD | -0,17 AUD |
2025e | 0,01 AUD | 0 AUD | -0,07 AUD |
2026e | 0 AUD | 0 AUD | -0,10 AUD |
2027e | 0 AUD | 0 AUD | -0,10 AUD |
chart_toolbar_3y
chart_toolbar_5y
chart_toolbar_10y
components_charts_BaseChart_0
chart_toolbar_max
components_charts_SharesOutstandingChart_8 | |
---|---|
2014 | 47,69 number_format_mio Aktien |
2015 | 47,69 number_format_mio Aktien |
2016 | 83,18 number_format_mio Aktien |
2017 | 98,58 number_format_mio Aktien |
2018 | 117,01 number_format_mio Aktien |
2019 | 144,08 number_format_mio Aktien |
2020 | 202,56 number_format_mio Aktien |
2021 | 212,18 number_format_mio Aktien |
2022 | 240,95 number_format_mio Aktien |
2023 | 289,67 number_format_mio Aktien |
2024 | 350,36 number_format_mio Aktien |
2025e | 350,36 number_format_mio Aktien |
2026e | 350,36 number_format_mio Aktien |
2027e | 350,36 number_format_mio Aktien |
components_ESGRating_35 | |
components_ESGRating_36 | |
components_ESGRating_37 | |
components_ESGRating_38 | |
components_ESGRating_11 | |
components_ESGRating_39 | |
components_ESGRating_47 | |
components_ESGRating_24 | |
components_ESGRating_42 | |
components_ESGRating_49 | |
components_ESGRating_48 | |
components_ESGRating_50 | |
components_ESGRating_44 | |
components_ESGRating_8 | |
components_ESGRating_12 | |
components_ESGRating_13 | |
components_ESGRating_16 | |
components_ESGRating_17 | |
components_ESGRating_18 | |
components_ESGRating_19 |
components_ESGRating_20 | |
components_ESGRating_21 | |
components_ESGRating_25 | |
components_ESGRating_26 | |
components_ESGRating_29 | |
components_ESGRating_30 | |
components_ESGRating_27 | |
components_ESGRating_28 | |
components_ESGRating_31 | |
components_ESGRating_32 | |
components_ESGRating_22 | |
components_ESGRating_23 | |
components_ESGRating_51 | |
components_ESGRating_41 | |
components_ESGRating_43 | |
components_ESGRating_46 | |
components_ESGRating_9 | |
components_ESGRating_10 | |
components_ESGRating_15 | |
components_ESGRating_33 |
components_ESGRating_40 | |
components_ESGRating_34 | |
components_ESGRating_45 | |
components_ESGRating_14 |
components_ESGRating_4 components_ESGRating_52 components_ESGRating_5
components_OwnershipTable__4 | components_OwnershipTable__0 | components_OwnershipTable__1 | components_OwnershipTable__2 | components_OwnershipTable__3 |
---|---|---|---|---|
6,08188 % | Allianz Global Investors Asia Pacific Limited | 21 308 735 | 1 431 199 | 17.05.2024 |
5,91577 % | Rennie (Paul) | 20 726 750 | 0 | 11.02.2025 |
4,32370 % | Sandhurst Trustees Ltd. | 15 148 692 | 15 148 692 | 14.08.2024 |
3,28801 % | RBC Global Asset Management (Asia) Limited | 11 520 012 | 1 200 000 | 31.12.2024 |
2,06451 % | Netwealth Investments Ltd. | 7 233 311 | 33 894 | 14.08.2024 |
1,74938 % | Clucas (Evan Philip) | 6 129 195 | 2 921 282 | 14.08.2024 |
0,99206 % | Wilson-Ghosh (Nancy Edith) | 3 475 835 | 0 | 14.08.2024 |
0,70526 % | HUB24 Limited | 2 470 966 | -145 176 | 14.08.2024 |
0,69281 % | 39KP Pty. Ltd. | 2 427 367 | 958 373 | 14.08.2024 |
0,68643 % | Huts (Adam William) | 2 405 000 | 2 405 000 | 14.08.2024 |
components_charts_SupplyChainChart_0 | components_charts_SupplyChainChart_1 | components_charts_SupplyChainChart_2 | components_charts_SupplyChainChart_3 | components_charts_SupplyChainChart_4 | components_charts_SupplyChainChart_5 | components_charts_SupplyChainChart_6 | components_charts_SupplyChainChart_7 |
---|---|---|---|---|---|---|---|
components_charts_SupplyChainChart_9components_charts_SupplyChainChart_10 | 0,50 | 0,26 | 0,56 | -0,74 | -0,74 | -0,75 |
pages_aktie_[isin]__12
pages_aktie_[isin]__15
pages_aktie_[isin]__18
pages_aktie_[isin]__21
pages_aktie_[isin]__24
pages_aktie_[isin]__28
pages_aktie_[isin]__30
pages_aktie_[isin]__34
pages_aktie_[isin]__36
pages_aktie_[isin]__40
pages_aktie_[isin]_[key]_index_1
pages_aktie_[isin]_[key]_index_3
pages_aktie_[isin]_[key]_index_5
pages_aktie_[isin]_[key]_index_7
pages_aktie_[isin]_[key]_index_9
pages_aktie_[isin]_[key]_index_14
pages_aktie_[isin]_[key]_index_15
pages_aktie_[isin]_[key]_index_18
pages_aktie_[isin]_[key]_index_20
pages_aktie_[isin]_[key]_index_22
components_Profile_Tickers_1 | Paradigm Biopharmaceuticals components_Profile_Tickers_2 |
---|---|
ASX | PAR.AX |
PNK | PBIGF |
Paradigm Biopharmaceuticals components_Profile_Tickers_2 | Paradigm Biopharmaceuticals FIGI |
---|---|
PAR:AU | BBG009QNWX21 |
PAR:AT | BBG009QNWX30 |
PAR:AH | BBG009QNWX76 |
PBIGF:US | BBG00MTX3SR3 |
PBIGF:PQ | BBG00MTX3T73 |
PBIGF:UV | BBG00MTX3T91 |
components_SimilarSitesList_0